National Comprehensive Cancer Network



About NCCN

Kidney/Testicular Cancers Panel - Disclosures as of 8/15/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Neeraj Agarwal, MD

None

None

None

None

None

Clair Beard, MD

None

None

None

None

None

Sam Bhayani, MD

None

None

None

None

None

Graeme B. Bolger, MD

None

Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Wyeth Pharmaceuticals

None

None

None

Mark K. Buyyounouski, MD, MS

None

None

None

None

None

Michael A. Carducci, MD

None

Active Biotech AB;
Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Centocor, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Astellas;
Kinex;
Medivation;
Pfizer Inc.;
sanofi-aventis U.S.;
Takeda Pharmaceuticals North America, Inc.

None

None

None

Sam S. Chang, MD

None

None

None

None

None

Toni K. Choueiri, MD

None

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
AVEO Pharmaceuticals, Inc.;
Pfizer Inc.

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Shilpa Gupta, MD

None

None

None

None

None

Hans-Joerg Hammers, MD, PhD

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

None

None

Steven L. Hancock, MD

None

None

None

None

None

Gary R. Hudes, MD

None

OSI Pharmaceuticals, Inc.;
AVEO;
Pfizer Inc.

None

None

None

Eric Jonasch, MD

None

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Aveo Pharmaceuticals;
Pfizer Inc.

None

None

None

Rashmi Kumar, PhD

None

None

None

None

None

Timothy M. Kuzel, MD

None

Boehringer Ingelheim GmbH;
Celgene Corporation;
Cell Therapeutics, Inc.;
Centocor, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Prometheus Laboratories;
Prometheus Laboratories;
Vicus Therapeutics;
Pfizer Inc.

None

None

None

Clayton Lau, MD

None

None

None

None

None

Ellis G. Levine, MD

None

None

None

UpToDate

None

Daniel W. Lin, MD

None

None

None

None

None

Kim A. Margolin, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

M. Dror Michaelson, MD, PhD

None

Genentech, Inc.;
Pfizer Inc.

None

None

None

Robert J. Motzer, MD

None

AstraZeneca Pharmaceuticals LP

None

None

None

Thomas Olencki, DO

None

Genentech, Inc.;
Pfizer Inc.

None

None

None

Roberto Pili, MD

Pfizer Inc.

Genentech, Inc.;
Genentech, Inc.;
Pfizer Inc.;
Pfizer Inc.;
Wyeth Pharmaceuticals;
Wyeth Pharmaceuticals

None

None

None

Thomas W. Ratliff, MD

None

Bayer HealthCare;
GlaxoSmithKline

None

None

None

Bruce G. Redman, DO

None

None

None

None

None

Cary N. Robertson, MD

None

Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
EDAP TMS, Inc.;
Endo Pharmaceuticals

None

None

None

Charles J. Ryan, MD

None

None

None

None

None

Joel Sheinfeld, MD

None

None

None

None

None

Jue Wang, MD

None

None

None

None

None

Richard B. Wilder, MD

None

None

None

None

None